Patients suffering from myocardial infarction who receive early add-on lipid-lowering medication have a significantly better ...

The Philippine Health Insurance Corporation (PhilHealth) has paid the Philippine General Hospital (PGH) PHP22.8 million for ...

A team of cardiology researchers at Yonsei University's Yongin Severance Hospital has published a study that hypothermic ...

A series of new studies from the National Kidney Foundation Spring Clinical Meeting exhibit the association between impaired kidney function and prolonged hospital stays, higher charges, and greater ...

In the Phase III EXPECTS trial, patients experiencing mostly mild posterior circulation ischemic stroke who were ineligible ...

The following is a summary of “Association of Early Noninvasive Cardiac Stress Testing With Acute Myocardial Infarction and ...

QUEZON CITY, (PIA) – The Philippine Health Insurance Corporation (PhilHealth) paid the sum of P22.8 million to the Philippine ...

Reducing “bad” cholesterol in the blood can stabilise changes in the vessels and cut the risk of new events, the scientists ...

HUMACAO, PR AND NEW YORK, NY / ACCESS Newswire / April 14, 2025 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the ...

SGLT2 inhibitors vs placebo were associated with reduced heart failure hospitalization among patients with history of myocardial infarction.

Cardiovascular disease is by far the most common cause of death worldwide, and myocardial infarction is the most common acute ...